Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL - Get Free Report) shares hit a new 52-week high during mid-day trading on Monday . The company traded as high as $17.04 and last traded at $16.5090, with a volume of 366423 shares changing hands. The stock had previously closed at $16.01.
Wall Street Analysts Forecast Growth
ANL has been the topic of a number of recent analyst reports. Leerink Partners initiated coverage on shares of Adlai Nortye in a research report on Friday, March 20th. They issued an "outperform" rating and a $23.00 target price on the stock. Wall Street Zen raised shares of Adlai Nortye to a "hold" rating in a research report on Saturday, March 7th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Adlai Nortye in a research report on Wednesday, January 21st. Finally, HC Wainwright upped their target price on shares of Adlai Nortye from $16.00 to $20.00 and gave the company a "buy" rating in a research report on Monday. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, Adlai Nortye has a consensus rating of "Hold" and an average target price of $21.50.
Get Our Latest Analysis on Adlai Nortye
Adlai Nortye Price Performance
The stock's 50-day simple moving average is $9.29 and its 200 day simple moving average is $4.70.
About Adlai Nortye
(
Get Free Report)
Adlai Nortye Inc NASDAQ: ANL is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.
Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.
The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Adlai Nortye, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Adlai Nortye wasn't on the list.
While Adlai Nortye currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
